NANOMOL TECHNOLOGIES is a science and innovation driven company providing cutting edge solutions to process, structure and characterize, at micro and nanoscale, active molecules of pharma, biotech and cosmetic companies. Our mission is to generate revolutionary nanomedicines and drug delivery systems with outstanding therapeutic efficacy and patient’s compliance.

NANOMOL TECHNOLOGIES born in UAB Research Park by the end of 2010, is a spin-off company co-founded by researchers of Nanomol research group of the Materials Science Institute of Barcelona ICMAB-CSIC and Networking Center on Biomedical Research CIBER-BBN. This group belongs to TECNIO network, the brand name created by Catalan Agency ACC1Ó to join Catalan research groups with strongest activities in applied research and technology transfer.

Over the last fifteen years, we have worked to develop and apply new technologies based on the use of compressed and supercritical fluids for preparing micro and nanoparticulate materials in one single process step. Compressed fluids or supercritical fluids are classified as green solvents and are being proposed as alternative solvents in many manufacturing processes. These technologies allow the production of materials with high added value in the form of powders, dispersion or emulsion, with beneficial properties in terms of administration and application. They provide a response to common problems encountered in pharmaceutical development such as the low selectivity and high toxicity with which some active molecules act in the organism, the high dosage rate required, and further limitations such as a low bioavailability of therapeutic active molecules or their inability to penetrate biological membranes.

NANOMOL TECHNOLOGIES

Org chart

Teams

Offices